Carestream Earns 42 U.S. Patents in 2018

Published on: January 15, 2019

ROCHESTER, N.Y., Jan. 15 — Carestream Health was awarded 42 new patents from the U.S. Patent and Trademark Office last year for innovation in digital radiography, extremity CT imaging and other healthcare technology areas. The company also received 37 additional patents in European and Asian countries last year.

“These valuable patents demonstrate our continued success in developing advanced diagnostic imaging technologies that serve healthcare providers around the world,” said Susan Parulski, Carestream’s Chief Patent Counsel. “Our employees are committed to delivering new products that can enhance image quality, deliver greater productivity and offer new capabilities to help improve the quality of patient care.”

New patents earned by the company’s scientists and engineers include:

New medical image capture technologies related to the development of computed tomography (CT) systems designed for extremity exams; and
Continued technology advances that further enhance the image quality delivered by Carestream’s growing portfolio of radiology imaging systems and detectors.

The company’s product portfolio includes digital imaging systems for general radiology and specialty areas such as orthopaedics and pediatrics; digital laser imagers that output medical images to film and paper; and the latest healthcare IT solutions and cloud-based services for hospitals, clinics and physician practices.

Around the web

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.